Intermediate Principles of Medical Cannabis: Clinical Case Study – Autism, Depression and Anxiety
-
Overview
Chad, a 19-year-old autistic male, seeks supports to help him manage his meltdowns and secondary anxiety and depression.
Despite already implementing a wide range of supports and medications to alleviate his distress and manage his aggressive behaviour, Chad's mother Linda, is looking to medical cannabis to supplement his current plan.
In this case study, we explore how Chad's team prescribed a combination of medical cannabis products to address Chad's distress and improve his quality of life.
Preview this case study by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this case study, you’ll be able to:
- Define "neurotype"
- Explain the purpose of neuroaffirming patient-centric practice
- Identify strategies to deliver neuroaffirming practice
- Explain the similarities and differences between autistic and allistic individuals
- Discuss conventional treatment options for managing distress in autistic individuals
- Discuss the potential benefits and limitations of medical cannabis as a treatment option for autistic individuals with anxiety and depression
- Identify suitable candidates for medical cannabis treatment
- Facilitate clinical discussions with patients and carers around medical cannabis as a therapeutic option for distress secondary to autistic traits
- Devise treatment plans that consider patient safety and minimise risk
- Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Overview
Chad, a 19-year-old autistic male, seeks supports to help him manage his meltdowns and secondary anxiety and depression.
Despite already implementing a wide range of supports and medications to alleviate his distress and manage his aggressive behaviour, Chad's mother Linda, is looking to medical cannabis to supplement his current plan.
In this case study, we explore how Chad's team prescribed a combination of medical cannabis products to address Chad's distress and improve his quality of life.
Preview this case study by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this case study, you’ll be able to:
- Define "neurotype"
- Explain the purpose of neuroaffirming patient-centric practice
- Identify strategies to deliver neuroaffirming practice
- Explain the similarities and differences between autistic and allistic individuals
- Discuss conventional treatment options for managing distress in autistic individuals
- Discuss the potential benefits and limitations of medical cannabis as a treatment option for autistic individuals with anxiety and depression
- Identify suitable candidates for medical cannabis treatment
- Facilitate clinical discussions with patients and carers around medical cannabis as a therapeutic option for distress secondary to autistic traits
- Devise treatment plans that consider patient safety and minimise risk
- Offer effective patient education and treatment advice on the therapeutic use of medical cannabis